Biomaxima (BMX) - Total Liabilities

Latest as of September 2025: zł30.50 Million PLN ≈ $8.39 Million USD

Based on the latest financial reports, Biomaxima (BMX) has total liabilities worth zł30.50 Million PLN (≈ $8.39 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BMX long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Biomaxima - Total Liabilities Trend (2009–2024)

This chart illustrates how Biomaxima's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Biomaxima.

Biomaxima Competitors by Total Liabilities

The table below lists competitors of Biomaxima ranked by their total liabilities.

Company	Country	Total Liabilities
Buxton Resources Ltd AU:BUX	Australia	AU$300.90K
Compucom Software Limited NSE:COMPUSOFT	India	Rs-1.42 Billion
IRIDEX Corporation NASDAQ:IRIX	USA	$23.62 Million
MMAG Holdings Bhd KLSE:0034	Malaysia	RM566.18 Million
Fevertree Drinks Plc LSE:FEVR	UK	GBX63.90 Million
Motio Ltd AU:MXO	Australia	AU$1.67 Million
Nusantara Voucher Distribution Tbk PT JK:DIVA	Indonesia	Rp76.79 Billion
RE Royalties Ltd V:RE	Canada	CA$45.99 Million

Liability Composition Analysis (2009–2024)

This chart breaks down Biomaxima's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See BMX equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.41	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.39	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Biomaxima's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Biomaxima (2009–2024)

The table below shows the annual total liabilities of Biomaxima from 2009 to 2024.

Year	Total Liabilities	Change
2024-12-31	zł29.01 Million ≈ $7.98 Million	+8.21%
2023-12-31	zł26.81 Million ≈ $7.38 Million	+22.05%
2022-12-31	zł21.96 Million ≈ $6.05 Million	-32.90%
2021-12-31	zł32.74 Million ≈ $9.01 Million	+19.08%
2020-12-31	zł27.49 Million ≈ $7.57 Million	+2.42%
2019-12-31	zł26.84 Million ≈ $7.39 Million	-1.01%
2018-12-31	zł27.11 Million ≈ $7.46 Million	+173.06%
2017-12-31	zł9.93 Million ≈ $2.73 Million	+50.85%
2016-12-31	zł6.58 Million ≈ $1.81 Million	+4.07%
2015-12-31	zł6.33 Million ≈ $1.74 Million	-8.73%
2014-12-31	zł6.93 Million ≈ $1.91 Million	-15.73%
2013-12-31	zł8.22 Million ≈ $2.26 Million	+24.03%
2012-12-31	zł6.63 Million ≈ $1.82 Million	+25.67%
2011-12-31	zł5.28 Million ≈ $1.45 Million	+39.96%
2010-12-31	zł3.77 Million ≈ $1.04 Million	+48.18%
2009-12-31	zł2.54 Million ≈ $700.15K	--

About Biomaxima

WAR:BMX Poland Diagnostics & Research

Market Cap

$11.66 Million

zł42.35 Million PLN

Market Cap Rank

#26772 Global

#286 in Poland

Share Price

zł10.10

Change (1 day)

+0.00%

52-Week Range

zł9.30 - zł14.25

All Time High

zł55.45